N. Carpentier

Mapping the APP/Presenilin (PS) Binding Domains: The Hydrophilic N-Terminus of PS2 Is Sufficient for Interaction with APP and Can Displace APP/PS1 Interaction

L. Buée, B. Tocqué, C. Czech, 1999, Neurobiology of Disease.

Metabolism of dichlorobiphenyls by hepatic microsomal cytochrome P-450.

L. Kaminsky, M. Kennedy, N. Carpentier, 1980, Biochemical pharmacology.

Metabolism of monochlorobiphenyls by hepatic microsomal cytochrome P-450.

L. Kaminsky, M. Kennedy, S. M. Adams, 1980, Biochemical pharmacology.

Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures

F. Terro, J. Hugon, C. Czech, 1998, Neuroscience.

Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients

P. Marquet, C. Sabot, J. Debord, 1998, European Journal of Clinical Pharmacology.

Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols

M. Millan, D. Cussac, A. Newman-Tancredi, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes

M. Millan, D. Cussac, A. Newman-Tancredi, 2002, Journal of Pharmacology and Experimental Therapeutics.

Persistence of the Nitric Oxide Pathway in the Aorta of Hypercholesterolemic Apolipoprotein-E-Deficient Mice

P. Vanhoutte, J. Vilaine, N. Villeneuve, 2003, Journal of Vascular Research.